A detailed history of Goldman Sachs Group Inc transactions in Sight Sciences, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 88,660 shares of SGHT stock, worth $356,413. This represents 0.0% of its overall portfolio holdings.

Number of Shares
88,660
Previous 35,057 152.9%
Holding current value
$356,413
Previous $233,000 139.48%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.49 - $8.31 $294,280 - $445,440
53,603 Added 152.9%
88,660 $558,000
Q2 2024

Aug 13, 2024

BUY
$5.13 - $7.15 $179,842 - $250,657
35,057 New
35,057 $233,000
Q2 2023

May 14, 2024

SELL
$7.46 - $10.67 $34,144 - $48,836
-4,577 Reduced 14.92%
26,100 $216,000
Q2 2023

Aug 14, 2023

SELL
$7.46 - $10.67 $34,144 - $48,836
-4,577 Reduced 14.92%
26,100 $216,000
Q1 2023

May 14, 2024

BUY
$8.44 - $13.35 $103,094 - $163,070
12,215 Added 66.16%
30,677 $268,000
Q1 2023

May 11, 2023

BUY
$8.44 - $13.35 $103,094 - $163,070
12,215 Added 66.16%
30,677 $268,000
Q4 2022

May 14, 2024

SELL
$5.58 - $13.94 $983,441 - $2.46 Million
-176,244 Reduced 90.52%
18,462 $225,000
Q4 2022

Feb 13, 2023

SELL
$5.58 - $13.94 $983,441 - $2.46 Million
-176,244 Reduced 90.52%
18,462 $225,000
Q3 2022

May 14, 2024

BUY
$6.1 - $11.41 $29,798 - $55,737
4,885 Added 2.57%
194,706 $1.24 Million
Q3 2022

Nov 10, 2022

BUY
$6.1 - $11.41 $29,798 - $55,737
4,885 Added 2.57%
194,706 $1.24 Million
Q2 2022

May 14, 2024

BUY
$6.61 - $11.99 $1.25 Million - $2.28 Million
189,821 New
189,821 $1.71 Million
Q2 2022

Aug 15, 2022

BUY
$6.61 - $11.99 $1.25 Million - $2.28 Million
189,821 New
189,821 $1.71 Million
Q4 2021

Feb 14, 2022

SELL
$17.36 - $27.36 $654,958 - $1.03 Million
-37,728 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$22.34 - $39.1 $842,843 - $1.48 Million
37,728 New
37,728 $856,000

Others Institutions Holding SGHT

About Sight Sciences, Inc.


  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $192M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.